Watters …show more content…
They convinced themselves it would be worth pushing through loopholes in the Japanese drug approval process as well as the "direct-to-consumer advertising rules" (Watters 525) unethically, in order to get the drug to the Japanese people earlier. Of course not twelve years earlier because there had not been the possibility of money involved at that time.
The drug companies insisted that their ethical reason to cure the world of depression was worth unethically pushing through loopholes in the Japanese advertising rules. Such loopholes included using the Internet to circumvent the "direct-to-consumer advertising rules" as well as fabricating "patient advocacy groups that were actually created by the drug companies themselves" (Watters 525). Another instance where the "direct-to-consumer advertising rule" was bypassed was in the trial stages where the drug makers would "often [buy] full page ads in newspapers in the guise of recruiting test subjects" (Watters …show more content…
The ethical sugar coating had been enough for GlaxoSmithKline to make billions off of a drug that does not even have a proven scientific result. This happened because they "offered grants to sponsor research on their drugs" and only kept "those researchers who produced results favorable to the drugs" while at the same time dismissing any contradictory evidence (Watters 527). Then they proceeded to market the fact that they have had renowned researchers and scientists to test and prove that their drug does work. This method left a lot of room for biased